Manufacturers’ views on outcome-based agreements
Introduction: utcome-based agreements (OBAs) are occasionally deployed to relieve the burden of high drug prices on healthcare budgets. However, it is not clear when manufacturers are willing to collaborate in establishing such agreements. Therefore, we explored the feasibility of OBAs from the manu...
Guardado en:
Autores principales: | Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Lonneke Timmers, Anke Pisters-van Roy, Joël Gijzen, Nicole M.A. Blijlevens, Haiko Bloemendal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2c82add5c86d4c679c4a8eb4cffafd74 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MANDATORY LABELLING OF NANOFOODS AND THE WTO AGREEMENTS
por: Nor Akhmal Hasmin, et al.
Publicado: (2020) -
Selecting University Technology Transfer Modes: An Examination of Biotechnology Firms' Entrepreneurial Orientation
por: Kirkman,Dorothy M
Publicado: (2013) -
Report of the Expert Group Meeting to discuss assessment of the performance of Caricom extraregional trade agreements
Publicado: (2015) -
Agreement and Fula pronouns
por: Christopher Culy
Publicado: (1996) -
Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial
por: Florence Bourgeois, et al.
Publicado: (2020)